Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7600.T Stock Summary
In the News
7600.T Financial details
Company Rating
Buy
Market Cap
19.88B
Income
1.02B
Revenue
22.68B
Book val./share
922
Cash/share
76.87
Dividend
13
Dividend %
1.69%
Employees
488
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
19.09
Forward P/E
9.77
PEG
-3.66
P/S
0.91
P/B
0.82
P/C
9.42
P/FCF
-
Quick Ratio
2.1
Current Ratio
5.85
Debt / Equity
0.08
LT Debt / Equity
0.02
-
-
EPS (TTM)
38.67
EPS next Y
74.1
EPS next Q
-
EPS this Y
-33.26%
EPS next Y
91.62%
EPS next 5Y
120.33%
EPS last 5Y
-6.39%
Revenue last 5Y
4.96%
Revenue Q/Q
8.86%
EPS Q/Q
104.47%
-
-
-
-
SMA20
2.65%
SMA50
-3.79%
SMA100
3.52%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.06%
Gross Margin
65%
Oper. Margin
8%
Profit Margin
5%
Payout
-
Shs Outstand
26.33M
Shs Float
14.59M
-
-
-
-
Target Price
-
52W Range
645.0-1153.0
52W High
-37.21%
52W Low
+12.25%
RSI
51
Rel Volume
0.48
Avg Volume
97.95K
Volume
46.7K
Perf Week
0.56%
Perf Month
1.4%
Perf Quarter
-3.21%
Perf Half Y
-3.6%
-
-
-
-
Beta
0.417
-
-
Volatility
10.03%, 20.09%
Prev Close
-2.03%
Price
724
Change
-1.5%
7600.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 633.64 | 685.11 | 634.41 | 727.46 | 808.6 | |
Net income per share | 75.17 | 82.02 | 63.09 | 80.95 | 54.03 | |
Operating cash flow per share | 89.67 | 103.47 | 98.54 | 117.94 | 82.96 | |
Free cash flow per share | 10.36 | 35.83 | 46.54 | 57.86 | 33.04 | |
Cash per share | 85.66 | 95.2 | 93.48 | 98.2 | 106.44 | |
Book value per share | 575.3 | 641.35 | 706.06 | 810.59 | 878.94 | |
Tangible book value per share | 570.09 | 633.12 | 699.62 | 803.49 | 873.91 | |
Share holders equity per share | 575.3 | 641.35 | 706.06 | 810.59 | 878.94 | |
Interest debt per share | 175.59 | 159.6 | 118.64 | 71.2 | 71.72 | |
Market cap | 29.44B | 43.16B | 59.76B | 43.22B | 27.43B | |
Enterprise value | 31.71B | 44.77B | 60.38B | 42.47B | 26.5B | |
P/E ratio | 14.83 | 19.93 | 35.9 | 20.24 | 19.27 | |
Price to sales ratio | 1.76 | 2.39 | 3.57 | 2.25 | 1.29 | |
POCF ratio | 12.43 | 15.8 | 22.99 | 13.89 | 12.55 | |
PFCF ratio | 107.63 | 45.64 | 48.67 | 28.31 | 31.51 | |
P/B Ratio | 1.94 | 2.55 | 3.21 | 2.02 | 1.18 | |
PTB ratio | 1.94 | 2.55 | 3.21 | 2.02 | 1.18 | |
EV to sales | 1.9 | 2.48 | 3.61 | 2.21 | 1.24 | |
Enterprise value over EBITDA | 9.12 | 11.05 | 16.98 | 10.51 | 7.36 | |
EV to operating cash flow | 13.39 | 16.39 | 23.23 | 13.65 | 12.12 | |
EV to free cash flow | 115.93 | 47.35 | 49.18 | 27.82 | 30.44 | |
Earnings yield | 0.07 | 0.05 | 0.03 | 0.05 | 0.05 | |
Free cash flow yield | 0.01 | 0.02 | 0.02 | 0.04 | 0.03 | |
Debt to equity | 0.3 | 0.24 | 0.17 | 0.09 | 0.08 | |
Debt to assets | 0.19 | 0.17 | 0.12 | 0.07 | 0.06 | |
Net debt to EBITDA | 0.65 | 0.4 | 0.18 | -0.18 | -0.26 | |
Current ratio | 2.88 | 4.26 | 5.76 | 6.22 | 5.51 | |
Interest coverage | 21.39 | 32.82 | 53.14 | 89.61 | 111.58 | |
Income quality | 1.09 | 1.04 | 1.28 | 1.13 | 1.24 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.11 | 0.11 | 0.16 | 0.14 | 0.22 | |
Sales general and administrative to revenue | 0.17 | 0.16 | 0.14 | 0.15 | 0.17 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.88 | -0.65 | -0.53 | -0.51 | -0.6 | |
Capex to revenue | -0.13 | -0.1 | -0.08 | -0.08 | -0.06 | |
Capex to depreciation | -1.8 | -1.29 | -0.99 | -1.12 | -0.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 986.42 | 1.09K | 1K | 1.22K | 1.03K | |
ROIC | 0.1 | 0.1 | 0.08 | 0.09 | 0.07 | |
Return on tangible assets | 0.09 | 0.09 | 0.07 | 0.08 | 0.05 | |
Graham Net | 49.21 | 85.73 | 150.33 | 215.9 | 243.56 | |
Working capital | 9.66B | 12.12B | 13.48B | 15.15B | 16.35B | |
Tangible asset value | 15.05B | 16.71B | 18.46B | 21.2B | 23.03B | |
Net current asset value | 6.54B | 7.91B | 9.83B | 12.2B | 13.83B | |
Invested capital | 0.3 | 0.24 | 0.17 | 0.09 | 0.08 | |
Average receivables | 4.63B | 4.5B | 4.45B | 4.85B | 5.24B | |
Average payables | 899.05M | 934.29M | 696.35M | 685.15M | 882.43M | |
Average inventory | 7.07B | 8.22B | 8.97B | 9.67B | 10.85B | |
Days sales outstanding | 99.84 | 89.39 | 97.64 | 99.13 | 90.29 | |
Days payables outstanding | 78.72 | 55.87 | 40.11 | 46.22 | 48.86 | |
Days of inventory on hand | 573.79 | 601.86 | 634.21 | 593.92 | 579.05 | |
Receivables turnover | 3.66 | 4.08 | 3.74 | 3.68 | 4.04 | |
Payables turnover | 4.64 | 6.53 | 9.1 | 7.9 | 7.47 | |
Inventory turnover | 0.64 | 0.61 | 0.58 | 0.61 | 0.63 | |
ROE | 0.13 | 0.13 | 0.09 | 0.1 | 0.06 | |
Capex per share | -79.31 | -67.65 | -52 | -60.08 | -49.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 214.05 | 216.09 | 205.42 | 210.83 | 229.41 | |
Net income per share | 15.86 | 10.83 | 6.74 | 6.93 | 14.17 | |
Operating cash flow per share | 30.12 | 29.06 | 29.53 | 30.39 | 30.37 | |
Free cash flow per share | 30.12 | 29.06 | 29.53 | 30.39 | 30.37 | |
Cash per share | 84.59 | 106.65 | 92.9 | 81.47 | 76.87 | |
Book value per share | 870.87 | 880.64 | 912.87 | 933.59 | 922 | |
Tangible book value per share | 864.33 | 875.6 | 908.83 | 929.87 | 924.78 | |
Share holders equity per share | 870.87 | 880.64 | 912.87 | 933.59 | 922 | |
Interest debt per share | 56.56 | 71.31 | 65.23 | 62.54 | 73.98 | |
Market cap | 23.72B | 27.38B | 26.75B | 19.82B | 19.99B | |
Enterprise value | 22.98B | 26.45B | 26.02B | 19.31B | 19.9B | |
P/E ratio | 14.2 | 24.04 | 37.72 | 27.16 | 13.39 | |
Price to sales ratio | 4.21 | 4.82 | 4.95 | 3.57 | 3.31 | |
POCF ratio | 29.91 | 35.82 | 34.44 | 24.78 | 25 | |
PFCF ratio | 29.91 | 35.82 | 34.44 | 24.78 | 25 | |
P/B Ratio | 1.03 | 1.18 | 1.11 | 0.81 | 0.82 | |
PTB ratio | 1.03 | 1.18 | 1.11 | 0.81 | 0.82 | |
EV to sales | 4.08 | 4.65 | 4.82 | 3.48 | 3.29 | |
Enterprise value over EBITDA | 23.66 | 31.82 | 38.62 | 29.97 | 21.17 | |
EV to operating cash flow | 28.98 | 34.6 | 33.5 | 24.15 | 24.89 | |
EV to free cash flow | 28.98 | 34.6 | 33.5 | 24.15 | 24.89 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
Debt to equity | 0.06 | 0.08 | 0.07 | 0.07 | 0.08 | |
Debt to assets | 0.05 | 0.06 | 0.06 | 0.05 | 0.06 | |
Net debt to EBITDA | -0.76 | -1.12 | -1.09 | -0.79 | -0.09 | |
Current ratio | 6.75 | 5.51 | 6.31 | 5.85 | 5.54 | |
Interest coverage | 147.97 | 132.38 | 67.64 | 31.61 | 64.54 | |
Income quality | 1.9 | 2.68 | 4.39 | 4.38 | 2.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.18 | 0.17 | 0.18 | 0.18 | 0.17 | |
Research and developement to revenue | 0.03 | 0.04 | 0.03 | 0.05 | 0.04 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 557.43 | 463.19 | 372.07 | 381.57 | 542.23 | |
ROIC | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | 244.21 | 244.03 | 254.55 | 256.88 | 257.53 | |
Working capital | 16.48B | 16.35B | 17.15B | 17.15B | 16.86B | |
Tangible asset value | 22.75B | 23.03B | 23.9B | 24.48B | 24.12B | |
Net current asset value | 13.83B | 13.83B | 14.61B | 14.96B | 14.75B | |
Invested capital | 0.06 | 0.08 | 0.07 | 0.07 | 0.08 | |
Average receivables | 4.91B | 5.22B | 5.2B | 5.19B | 5.46B | |
Average payables | 1.06B | 1.03B | 945.24M | 1.05B | 1.16B | |
Average inventory | 11.99B | 11.65B | 11.98B | 12.57B | 12.73B | |
Days sales outstanding | 82.61 | 83.47 | 85.29 | 85.36 | 84.34 | |
Days payables outstanding | 49.53 | 44.37 | 42.86 | 52.68 | 46.93 | |
Days of inventory on hand | 537.16 | 525.92 | 580.82 | 571.03 | 521.33 | |
Receivables turnover | 1.09 | 1.08 | 1.06 | 1.05 | 1.07 | |
Payables turnover | 1.82 | 2.03 | 2.1 | 1.71 | 1.92 | |
Inventory turnover | 0.17 | 0.17 | 0.15 | 0.16 | 0.17 | |
ROE | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
7600.T Frequently Asked Questions
What is Japan Medical Dynamic Marketing, INC. stock symbol ?
Japan Medical Dynamic Marketing, INC. is a JP stock and trading under the symbol 7600.T
What is Japan Medical Dynamic Marketing, INC. stock quote today ?
Japan Medical Dynamic Marketing, INC. stock price is $724 today.
Is Japan Medical Dynamic Marketing, INC. stock public?
Yes, Japan Medical Dynamic Marketing, INC. is a publicly traded company.